Everything below concerns mass spectrometry. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-07-21. Where a claim depends on a specific study, the study is described rather than over-claimed.
The full name often given is N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide. This name indicates a chain containing tyrosine, isoleucine, and a six-carbon amino acid derivative. Databases list a CAS Registry Number and a molecular formula for the compound. The peptide is small compared with proteins, and its structure allows it to be studied in cell cultures and animal models. Exact identity depends on the supplier's synthesis and purification process. Minor impurities can remain after synthesis.
Chemically, dihexa belongs to a broader group of angiotensin IV analogs. Researchers have modified the natural peptide to alter stability, binding, or distribution. Such changes can affect how the molecule behaves in experiments. The parent peptide angiotensin IV is involved in various physiological processes, but the modified analog is not identical to it. Public summaries sometimes blur the distinction between the natural fragment and the synthetic research compound. This distinction matters when interpreting study results.
Dihexa is typically supplied as a lyophilized powder for laboratory research. Lyophilization removes water and improves stability during transport and storage. The solid is commonly stored at -20 °C or lower, desiccated, and protected from light. Repeated freeze-thaw cycles and exposure to moisture can degrade peptides, so aliquoting and sealed containers are standard practice in most laboratory settings. These handling measures apply to research-grade material and do not imply clinical suitability.
Purity and identity are usually assessed with reverse-phase high-performance liquid chromatography (RP-HPLC) and mass spectrometry. RP-HPLC separates components by hydrophobicity and can estimate peptide purity. Mass spectrometry confirms molecular mass and helps detect truncations or modifications. Some laboratories also use amino acid analysis or nuclear magnetic resonance for structural verification. A certificate of analysis from a supplier may list these results, but independent verification is often recommended for critical work.
Regulatory status varies by country, and dihexa is not widely approved as a medicine. In many jurisdictions it is treated as a research chemical, which limits its legal sale, possession, and human use. Products marketed online may lack verified purity or identity, and labels can be inaccurate. Researchers typically source material from suppliers that provide analytical documentation and follow institutional safety rules. Open questions remain about long-term stability, metabolite formation, and human pharmacokinetics.
| Property | Value | Notes |
|---|---|---|
| Common name | Dihexa | Shorthand used in research literature and supplier catalogs. |
| CAS Registry Number | 1401708-83-5 | Identifier assigned to the synthetic peptide. |
| Molecular formula | C27H44N4O5 | Reported formula; verify with a certificate of analysis. |
| Appearance | White to off-white powder | Typical form for lyophilized research peptides. |
| Typical storage | −20 °C or below, desiccated | Common condition for peptide stability. |
Dihexa is a synthetic peptide with the chemical name N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide, and it is structurally related to angiotensin IV, a naturally occurring peptide fragment. Researchers developed it as a modified analog intended to alter stability and activity relative to the parent peptide. Its short sequence and fatty acid chain distinguish it from many endogenous peptides, and published studies often describe it under the abbreviation dihexa. The compound is classified as a laboratory compound rather than an approved therapeutic in most jurisdictions.
Early laboratory work focused on its effects on synaptic connectivity and neuronal signaling. In cell and animal models, dihexa has been reported to promote the formation of new synapses, a process called synaptogenesis. These findings have generated interest in cognitive research, but the evidence base remains mostly preclinical. Human clinical trials with clear safety and efficacy endpoints are limited or absent in the public literature. Whether these effects translate to humans is an open question.
The proposed mechanism involves interaction with the hepatocyte growth factor (HGF) system and its receptor, c-Met. Dihexa is described in some studies as an HGF mimetic, meaning it may mimic or enhance HGF-mediated signaling. Activation of c-Met can influence cell growth, survival, and cytoskeletal remodeling, pathways that intersect with synaptic plasticity. However, the precise binding targets and downstream events for dihexa are not fully established, and alternative mechanisms have been suggested.
Dissolution depends on the peptide’s salt form, purity, and the chosen solvent. Dimethyl sulfoxide is commonly used to prepare concentrated stock solutions, while aqueous buffers may show limited solubility. Sonication or gentle warming can sometimes aid dissolution, but excessive heat may promote degradation. Once in solution, the material is generally kept cold and protected from light. Researchers should verify solubility for each lot rather than assuming uniform behavior across suppliers.
Quality control usually combines reverse-phase high-performance liquid chromatography with mass spectrometry. Chromatography estimates purity and detects related impurities, while mass spectrometry supports molecular identity. Nuclear magnetic resonance can provide additional structural confirmation when needed. Stability data for dihexa are limited, and degradation pathways may depend on pH, temperature, and moisture. Open questions include long-term stability in different formulations and the effect of repeated freeze-thaw cycles on measured purity. Such tests help confirm that a batch matches its label before use.
== Bulk properties == Thorium is a moderately soft, paramagnetic, bright silvery radioactive actinide metal that can be bent or shaped. In the periodic table, it lies to the right of actinium, to the left of protactinium, and below cerium. Pure thorium is very ductile and, as normal for metals, can be cold-rolled, swaged, and drawn. At room temperature, thorium metal has a face-centred cubic crystal structure; it has two other forms, one at high temperature (over 1360 °C; body-centred cubic) and one at high pressure (around 100 GPa; body-centred tetragonal). Thorium metal has a bulk modulus (a measure of resistance to compression of a material) of 54 GPa, about the same as tin's (58.2 GPa). Aluminium's is 75.2 GPa; copper's is 137.8 GPa; and mild steel's is 160–169 GPa. Thorium is about as hard as soft steel, so when heated it can be rolled into sheets and pulled into wire. Thorium is nearly half as dense as uranium and plutonium and is harder than both. Thorium has a magnetic susceptibility of 0.412 × 4π × 10−9 m3⋅kg−1 at room temperature. This susceptibility is mostly temperature-independent, however impurities and dopants can affect this value. It becomes superconductive below 1.4 K. Thorium's melting point of 1750 °C is above both those of actinium (1227 °C) and protactinium (1568 °C).
=== Arrests === A 1995 Bureau of Justice Statistics report found that from 1991 to 1993, 16% of those who sold drugs were black, but 49% of those arrested for doing so were black. A 2006 study concluded that blacks were significantly overrepresented for those arrested for drug delivery offenses in Seattle. The same study found that it was a result of law enforcement focusing on crack offenders and outdoor venues and dedicating resources to racially-heterogeneous neighborhoods. A 2010 study found little difference by race with regards to the rates of adolescent drug dealing. A 2012 study found that black youths were less likely than white youths to use or sell drugs but more likely to be arrested for doing so. A 2013 study by the American Civil Liberties Union determined that a black person in the United States was 3.73 times more likely to be arrested for marijuana possession than a white person, but both races have similar rates of marijuana use. Iowa had the highest racial disparity of the fifty states. Blacks in Iowa were arrested for marijuana possession at a rate 8.4 times higher than whites. One factor that may explain the difference in arrest rates between whites and blacks is that blacks are more likely than whites to buy marijuana outdoors, from a stranger, and away from home.
== References == All information about ministries was sourced from Ministries from December 1989, extracted from the Queensland Parliamentary Handbook. All information about events was sourced from the "Australian Political Chronicle" in various instalments of the Australian Journal of Politics and History.
Sources: en.wikipedia.org
Proteinogenic amino acids are amino acids that are incorporated biosynthetically into proteins during translation from RNA. The word "proteinogenic" means "protein creating". Throughout known life, there are 22 genetically encoded (proteinogenic) amino acids, 20 in the standard genetic code and an additional 2 (selenocysteine and pyrrolysine) that can be incorporated by special translation mechanisms. In contrast, non-proteinogenic amino acids are amino acids that are either not incorporated into proteins (like GABA, L-DOPA, or triiodothyronine), misincorporated in place of a genetically encoded amino acid, or not produced directly and in isolation by standard cellular machinery (like hydroxyproline). The latter often results from post-translational modification of proteins. Some non-proteinogenic amino acids are incorporated into nonribosomal peptides which are synthesized by non-ribosomal peptide synthetases. Both eukaryotes and prokaryotes can incorporate selenocysteine into their proteins via a nucleotide sequence known as a SECIS element, which directs the cell to translate a nearby UGA codon as selenocysteine (UGA is normally a stop codon). In some methanogenic prokaryotes, the UAG codon (normally a stop codon) can also be translated to pyrrolysine. In eukaryotes, there are only 21 proteinogenic amino acids, the 20 of the standard genetic code, plus selenocysteine. Humans can synthesize 12 of these from each other or from other molecules of intermediary metabolism.
=== Historical treatment === Levacetylmethadol (LAAM) was formerly used to treat opioid dependence. In 2003, its manufacturer discontinued production. There are no available generic versions. LAAM produced long-lasting effects, which allowed the person receiving treatment to visit a clinic only three times per week, as opposed to daily as with methadone. In 2001, LAAM was removed from the European market due to reports of life-threatening ventricular rhythm disorders. In 2003, Roxane Laboratories, Inc. discontinued it in the U.S.
== Description == Black Drop was a 19th-century dark medicine made of opium, vinegar, spices, often with sugar, sometimes called Black drops, and known in Great Britain and North America. One recipe for Black Drop began, "Macerate the opium and nutmeg in ... the diluted acetic acid, for seven days, stirring frequently". As well as Kendal Black Drop, there were versions called Lancaster and Armstrong's Black Drop. Other names given in a 19th-century Cyclopædia of Several Thousand Practical Receipts were Quaker's or Toustall's Black Drop, after a Dr. Toustall of the Society of Friends in County Durham who is said to have invented the recipe. In 1823, Byron referred to it in his poem Don Juan:
Sources: en.wikipedia.org
True muscle weakness (or neuromuscular weakness) describes a condition where the force exerted by the muscles is less than would be expected, for example muscular dystrophy. Perceived muscle weakness (or non-neuromuscular weakness) describes a condition where a person feels more effort than normal is required to exert a given amount of force but actual muscle strength is normal, for example myalgic encephalomyelitis/chronic fatigue syndrome. In some conditions, such as myasthenia gravis, muscle strength is normal when resting, but true weakness occurs after the muscle has been subjected to exercise. This is also true for some cases of chronic fatigue syndrome, where objective post-exertion muscle weakness with delayed recovery time has been measured and is a feature of some of the published definitions.
==== Ireland ==== Ireland has a brand of clear vanilla-flavored cream soda called Country Spring.. Country Spring was a soft drink brand made by the Gleeson Group[1], a company which was in turn purchased by C&C Group in 2012 [2]. Cream Soda made by A.G. Barr is also widely sold and consumed there.
==== 1.A α-type channels ==== 1.A.1 Voltage-gated ion channel superfamily 1.A.2 Inward-rectifier K+ channel family 1.A.3 Ryanodine-inositol-1,4,5-trisphosphate receptor Ca2+ channel family 1.A.4 Transient receptor potential Ca2+ channel family 1.A.5 Polycystin cation channel family 1.A.6 Epithelial Na+ channel family 1.A.7 ATP-gated P2X receptor cation channel family 1.A.8 Major intrinsic protein superfamily 1.A.9 Neurotransmitter receptor, Cys loop, ligand-gated ion channel family 1.A.10 Glutamate-gated ion channel family of neurotransmitter receptors 1.A.11 Ammonium channel transporter family 1.A.12 Intracellular chloride channel family 1.A.13 Epithelial chloride channel family 1.A.14 Testis-enhanced gene transfer family 1.A.15 Nonselective cation channel-2 family 1.A.16 Formate-nitrite transporter family 1.A.17 Calcium-dependent chloride channel family 1.A.18 Chloroplast envelope anion-channel-forming Tic110 family 1.A.19 Type A influenza virus matrix-2 channel family 1.A.20 BCL2/Adenovirus E1B-interacting protein 3 family 1.A.21 Bcl-2 family 1.A.22 Large-conductance mechanosensitive ion channel 1.A.23 Small-conductance mechanosensitive ion channel 1.A.24 Gap-junction-forming connexin family 1.A.25 Gap-junction-forming innexin family 1.A.26 Mg2+ transporter-E family 1.A.27 Phospholemman family 1.A.28 Urea transporter family 1.A.29 Urea/amide channel family 1.A.30 H+- or Na+-translocating bacterial MotAB flagellar motor/ExbBD outer-membrane transport energizer superfamily 1.A.31 Annexin family 1.A.32 Type B influenza virus NB channel family 1.A.33 Cation-channel-forming heat shock protein 70 family 1.A.34 Bacillus gap junction-like channel-forming complex family 1.A.35 CorA metal ion transporter family 1.A.36 Intracellular chloride channel family 1.A.37 CD20 Ca2+ channel family 1.A.38 Golgi pH regulator family 1.A.39 Type C influenza virus CM2 channel family 1.A.40 Human immunodeficiency virus type I Vpu channel family 1.A.41 Avian reovirus p10 Vvroporin family 1.A.42 HIV viral protein R family 1.A.43 Camphor resistance or fluoride exporter family 1.A.44 Pore-forming tail Tip pb2 protein of phage T5 family 1.A.45 Phage P22 injectisome family 1.A.46 Anion channel-forming bestrophin family 1.A.47 Nucleotide-sensitive anion-selective channel, ICln family 1.A.48 Anion channel Tweety family 1.A.49 Human coronavirus ns12.9 viroporin family 1.A.50 Phospholamban (Ca2+-channel and Ca2+-ATPase regulator) family 1.A.51 The Voltage-gated Proton Channel (VPC) Family 1.A.52 The Ca2+ Release-activated Ca2+ (CRAC) Channel (CRAC-C) Family 1.A.53 The Hepatitis C Virus P7 Viroporin Cation-selective Channel (HCV-P7) Family 1.A.54 The Presenilin ER Ca2+ Leak Channel (Presenilin) Family 1.A.55 The Synaptic Vesicle-Associated Ca2+ Channel, Flower (Flower) Family 1.A.56 The Copper Transporter (Ctr) Family 1.A.57 The Human SARS Coronavirus Viroporin (SARS-VP) 1.A.58 The Type B Influenza Virus Matrix Protein 2 (BM2-C) Family 1.A.59 The Bursal Disease Virus Pore-Forming Peptide, Pep46 (Pep46) Family 1.A.60 The Mammalian Reovirus Pre-forming Peptide, Mu-1 (Mu-1) Family 1.A.61 The Insect Nodavirus Channel-forming Chain F (Gamma-Peptide) Family 1.A.62 The Homotrimeric Cation Channel (TRIC) Family 1.A.63 The Ignicoccus Outer Membrane α-helical Porin (I-OMP Family 1.A.64 The Plasmolipin (Plasmolipin) Family 1.A.65 The Coronavirus Viroporin E Protein (Viroporin E) Family 1.A.66 The Pardaxin (Pardaxin) Family 1.A.67 The Membrane Mg2+ Transporter (MMgT) Family 1.A.68 The Viral Small Hydrophobic Viroporin (V-SH) Family 1.A.69 The Heteromeric Odorant Receptor Channel (HORC) Family 1.A.70 The Molecule Against Microbes A (MamA) Family 1.A.71 The Brain Acid-soluble Protein Channel (BASP1 Channel) Family 1.A.72 The Mer Superfamily 1.A.73 The Colicin Lysis Protein (CLP) Family 1.A.74 The Mitsugumin 23 (MG23) Family 1.A.75 The Mechanical Nociceptor, Piezo (Piezo) Family 1.A.76 The Magnesium Transporter1 (MagT1) Family 1.A.77 The Mg2+/Ca2+ Uniporter (MCU) Family 1.A.78 The K+-selective Channel in Endosomes and Lysosomes (KEL) Family 1.A.79 The Cholesterol Uptake Protein (ChUP) or Double Stranded RNA Uptake Family 1.A.80 The NS4a Viroporin (NS4a) Family 1.A.81 The Low Affinity Ca2+ Channel (LACC) Family 1.A.82 The Hair Cell Mechanotransduction Channel (HCMC) Family 1.A.83 The SV40 Virus Viroporin VP2 (SV40 VP2) Family 1.A.84 The Calcium Homeostasis Modulator Ca2+ Channel (CALHM-C) Family 1.A.85 The Poliovirus 2B Viroporin (2B Viroporin) Family 1.A.86 The Human Papilloma Virus type 16 (HPV16) L2 Viroporin (L2 Viroporin) Family 1.A.87 The Mechanosensitive Calcium Channel (MCA) Family 1.A.88 The Fungal Potassium Channel (F-Kch) Family 1.A.89 The Human Coronavirus 229E Viroporin (229E Viroporin) Family 1.A.90 The Human Metapneumovirus (HMPV) Viroporin (HMPV-Viroporin) Family 1.A.91 The Cytoadherence-linked Asexual Protein 3.2 of Plasmodium falciparum (Clag3) Family 1.A.92 The Reovirus Viroporin VP10 (RVP10) Family 1.A.93 The Bluetongue Virus Non-Structural Protein 3 Viroporin (NS3) Family 1.A.94 The Rotavirus Non-structural Glycoprotein 4 Viroporin (NSP4) Family 1.A.95 The Ephemerovirus Viroporin (EVVP) Family 1.A.96 The Human Polyoma Virus Viroporin (PVVP) Family 1.A.97 The Human Papillomavirus type 16 E5 Viroporin (HPV-E5) Family 1.A.98 Human T-Lymphotropic Virus 1 P13 protein (HTLV1-P13) Family 1.A.99 The Infectious Bronchitis Virus Envelope Small Membrane Protein E (IBV-E) Family 1.A.100 The Rhabdoviridae Putative Viroporin, U5 (RV-U5) Family 1.A.101 The Peroxisomal Pore-forming Pex11 (Pex11) Family 1.A.102 Influenza A viroporin PB1-F2 (PB1-F2) Family 1.A.103 The Simian Virus 5 (Parainfluenza Virus 5) SH (SV5-SH) Family 1.A.104 The Proposed Flagellar Biosynthesis Na+ Channel, FlaH (FlaH) Family 1.A.105 The Mixed Lineage Kinase Domain-like (MLKL) Family 1.A.106 The Calcium Load-activated Calcium Channel (CLAC) Family 1.A.107 The Pore-forming Globin (Globin) Family
Ana Leal got a hold of the photo from a computer of a pedophile that was killed and questioned the fact that fourteen pedophiles were identified in the series of 60 thousand photos, however the investigations did not move forward. At the time, the suspect was arrested temporarily. When the photo of the supposed Mendonça was presented to the media in October 2002, Sá Fernandes had not been able to access the PJ process for a month. That PJ attitude made the Mendonça family question what was actually happening. According to an investigation published by the Correio da Manhã in May 2019, the Judiciary Police "uses photos and secrets to deflect false information and photos of Rui Pedro". According to the Portuguese police, forensics proved that it was not Mendonça in the photos. The Benidorm video was not referenced.
Sources: en.wikipedia.org
Dihexa is a synthetic peptide modeled on angiotensin IV. It is used in laboratory and animal research, not as an approved medicine. Human effects remain poorly characterized.
It is produced by chemical synthesis, not extracted from plants or animals. Its design is based on a naturally occurring peptide fragment. Suppliers sell it as a research chemical.
No, dihexa is a modified analog of angiotensin IV. The two share a structural relationship but differ in chemical details. Research on one does not automatically apply to the other.
The lyophilized powder is generally stored at -20 °C or lower, desiccated, and protected from light. Solutions are often aliquoted to avoid repeated freeze-thaw cycles. Specific stability data may vary by formulation and purity.